ABCL Abcellera Biologics Inc
Company Analysis
Latest News
🟢 Abcellera Biologics is trading 4.1% up today on a technical bounce and biotech sector rotation
Abcellera Biologics is trading at $6.42 (+4.14%) as the stock stages a recovery following a sharp pullback in the previous session. • The advance appears to...
🔴 Abcellera Biologics is trading 6.1% down today on profit-taking after hitting a 52-week high
Abcellera Biologics is trading 6.1% down at $6.33 as investors lock in profits following a sharp rally to recent 52-week highs. • The stock recently reached a...
🟢 Abcellera Biologics is trading 4.5% up today on technical rebound after recent profit-taking
Abcellera Biologics is trading 4.5% up at $6.82, staging a technical recovery after several sessions of profit-taking followed a massive 40% rally. • The...
🔴 Abcellera Biologics is trading 4.2% down today on continued profit-taking following its recent 40% rally
Abcellera Biologics is trading 4.2% down at $6.51 as investors continue to take profits following a rally of more than 40% driven by upbeat Q1 2026 results and...
🔴 Abcellera Biologics is trading 5.4% down today on profit-taking after recent 40% rally
Abcellera Biologics is trading 5.4% down today at $6.90 as investors lock in profits following a sharp run-up in share price. • The stock recently gained more...
🔴 ABCL extends move to 5.5% down
ABCL is trading at $7.27, down 5.5% versus the comparison close of $7.69 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 ABCL is trading 4.8% down today as profit-taking follows oncology-driven rally
ABCL is trading 4.8% down at $7.32 as the stock extends a multi-day pullback following last week’s sharp oncology-driven rally. • Recent gains were fueled by...
🔴 ABCL is trading 4.7% down today as profit-taking extends pullback after oncology rally
ABCL is trading at $7.33 (4.7% down) in pre-market as the stock extends a two-day pullback following last week’s sharp oncology-driven rally. • The stock...
🔴 ABCL is trading 4% down today on profit-taking after recent oncology-driven rally
ABCL is trading 4% down at $7.55 as the stock undergoes a pullback following a sharp multi-day rally driven by positive oncology partnership news. • The...
🟢 ABCL is trading 4.2% up today after appointing oncology veteran Dr. Lynn Seely to its Board of Directors.
ABCL is trading at $8.20 (4.2% up) in pre-market following the appointment of Dr. Lynn Seely, an oncology veteran, to its Board of Directors. • Dr. Seely...
🟢 ABCL extends move to 6.2% up
ABCL is trading at $8.07, up 6.2% versus the comparison close of $7.60 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ABCL is trading 4.9% up today with no clear new catalyst
ABCL is trading 4.9% up now at $7.97 after several volatile sessions in late June and early July. Recent gains have followed earlier positive sentiment tied to...
🔴 ABCL extends move to 5.5% down
ABCL is trading at $7.42, down 5.5% versus the comparison close of $7.85 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 ABCL is trading 4.84% down today after profit-taking following a multi-session rally
ABCL is trading at $7.47 (4.84% down) today as the stock pulls back due to profit-taking following a sharp multi-session advance. • The decline appears to be...
🔴 ABCL is trading 5% down today on profit-taking after a multi-day rally
ABCL is trading 5% down today at $7.70 as the stock undergoes a pullback following a sharp multi-session advance. • The decline follows a significant run-up...
🟢 ABCL extends move to 5.2% up
ABCL is trading at $8.54, up 5.2% versus the comparison close of $8.12 during pre-market. This is a price-movement alert; no separate company-specific catalyst...
🟢 ABCL is trading 4.9% up today, extending its multi-day momentum on Jazz Pharmaceuticals collaboration
• ABCL is trading at $8.52 (+4.93%) in pre-market, continuing a strong multi-day rally. • The stock's momentum is driven by its recent preclinical research,...
🟢 ABCL makes sharp 14.0% jump
ABCL is trading at $8.41, up 14.0% versus the comparison close of $7.38 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ABCL Surges 6% on Technical Momentum and Major Jazz Pharmaceuticals Collaboration
ABCL is trading 6% up at $7.82, extending a multi-session rally. • The surge is driven by a recent major preclinical research collaboration deal with Jazz...
🟢 ABCL is trading 5.7% up today extending rally on golden cross and positive outlook
ABCL is trading at $7.80 (5.7%) up in pre-market, extending a strong multi-day rally driven by technical momentum and positive analyst sentiment. • The move...